Drug Effects on Learning in Children A Selective Review of the Past Thirty Years

Adamson, W. C. , Nellis, B. P. , Runge, G. , Cleland, C. , & Killian, E. Use of tranquilizers for mentally deficient patients. A.M.A. J. Dis. Child., 1958, 96, 159–164.

Alderton, H. R. , & Hoddinott, B. A. Controlled study of the use of thioridazine in the treatment of hyperactive and aggressive children in a children's psychiatric hospital. Canad. Psychiat. Ass. J., 1964, 9, 239–247.

Asatoor, A. M. , Levi, A. J. , & Milne, D. Tranylcypromine and cheese. Lancet, 1963, 2, 733–734.

Astin, A. W. , & Ross, S. Glutamic acid and human intelligence. Psychol. Bull., 1960, 57, 429–434.

Babich, F. R. , Jacobson, A. L. , Bubash, S. , & Jacobson, A. Transfer of a response to naive rats by injection of ribonucleic acid extracted from trained rats. Science, 1965, 149, 656–657.

Badham, J. N. , Bardon, L. M. , Reeves, P. O. , & Young, A. M. A trial of thioridazine in mental deficiency. Brit. J. Psychiat., 1963, 109, 408–410.

Bair, H. V. , & Herold, W. Efficiency of chlorpromazine in hyperactive mentally retarded children. A.M.A. Arch. Neurol. Psychiat., 1955, 74, 363–364.

Baird, H. W. III. Personal communication, 1966.

Beaudry, P. , & Gibson, D. Effect of trifluoperazine on the behavior disorders of children with malignant emotional disturbances. Amer. J. ment. Def., 1960, 64, 823–826.

Beecher, H. K. The powerful placebo. J.A.M.A., 1955, 159, 1602–1606.

Bell, A. , & Zubek, J. P. Effects of deanol on the intellectual performance of mental defectives. Canad. J. Psychol., 1961, 15, 172–175.

Benda, H. Promazine in mental deficiency. Psychiat. Quart., 1958, 32, 449–455.

Bender, L. Discussion [of Eisenberg's paper]. In S. Fisher (Ed.), Child research in psychopharmacology. Springfield, Ill.: Thomas, 1959. Pp. 35–42.

Bender, L. , & Cottington, F. The use of amphelamine sulfate (Benzedrine) in child psychiatry. Amer. J. Psychiat., 1942, 99, 116–121.

Bender, L. , & Faretra, G. Organic therapy in pediatric psychiatry. Dis. nerv. Syst., 1961, 22 (Suppl. 4), 110–111.

Bennett, I. F. Chemotherapy in psychiatric hospitals: critical review of the literature and research trends. In Transactions of the first research conference on chemotherapy in psychiatry. Washington: Veterans' Administration, 1957. Pp. 15–20.

Berger, F. M. Classification of psychoactive drugs according to their chemical structures and sites of action. In L. Uhr & J. G. Miller (Eds.), Drugs and behavior. New York: Wiley, 1960. Pp. 86–105.

Bindra, D. , & Mendelson, J. Training, drive level, and drug effects: a temporal analysis of their combined influence on behavior. J. comp. physiol. Psychol., 1963, 56, 183–189.

Black, D. B. , Kato, J. G. , & Walker, G. W. R. A study of improvement in mentally retarded children accruing from Siccacell therapy. Amer. J. ment. Del., 1966, 70, 499–508.

Boatman, M. J. , & Berlin, I. N. Some implications of incidental experiences with psychopharmacologic drugs in a children's psychotherapeutic program. J. Amer. Acad. Child Psychiat., 1962, 1, 431–442.

Bowman, P. W. , & Blumberg, E. Ataractic therapy of hyperactive, mentally retarded patients. J. Maine Med. Ass., 1958, 49, 272–273.

Bradley, C. The behavior of children receiving Benzedrine. Amer. J. Psychiat., 1937, 94, 577–585.

Bradley, C. Benzedrine and Dexedrine in the treatment of children's behavior disorders. Pediatrics, 1950, 5, 24–37.

Bradley, C. Characteristics and management of children with behavior problems associated with organic brain disease. Pediat. Clin. N. Amer., 1957, 4, 1049–1060.

Bradley, C. Tranquilizing drugs in pediatrics. Pediatrics, 1958, 21, 325–336.

Bradley, C. , & Bowen, M. School performance of children receiving amphetamine (Benzedrine) sulfate. Amer. J. Orthopsychiat., 1940, 10, 782–788.

Bradley, C. , & Bowen, M. Amphetamine (Benzedrine) therapy of children's behavior disorders. Amer. J. Orthopsychiat., 1941, 11, 92–103.

Bradley, C. , & Green, E. Psychometric performance of children receiving amphetamine (Benzedrine) sulfate. Amer. J. Psychiat., 1940, 97, 388–394.

Brown, H. Effect of ribonucleic acid (RNA) on the rate of lever pressing in rats. Psychol. Rec., 1966, 16, 173–176.

Cameron, D. E. The processes of remembering. Brit. J. Psychiat., 1963, 109, 325–340.

Cameron, D. E. , Sved, S. , Solyom, L. , & Wainrib, B. Ribonucleic acid in psychiatric therapy. In J. H. Masserman (Ed)., Current psychiatric therapies, Vol. IV. New York: Grune & Stratton, 1964. Pp. 127–133.

Chess, S. Diagnosis and treatment of the hyperactive child. N. Y. J. Med., 1960, 60, 2379–2385.

Cole, J. O. Evaluation of drug treatments in psychiatry. J. new Drugs, 1962, 2, 264–275.

Collipp, P. J. , Kaplan, S. A. , Kogut, M. D. , Tasem, W. , Plachte, F. , Schlamm, V. , Boyle, D. C. , Ling, S. M. , & Koch, R. Mental retardation in congenital hypothyroidism: improvement with thyroid replacement therapy. Amer. J. ment. Def., 1965, 70, 432–437.

Conners, C. K. , & Eisenberg, L. The effects of methylphenidate on symptomatology and learning in disturbed children. Amer. J. Psychiat., 1963, 120, 458–464.

Conners, C. K. , Eisenberg, L. , & Sharpe, L. Effects of methylphenidate (Ritalin) on paired-associate learning and Porteus maze performance in emotionally disturbed children. J. consult. Psychol., 1964, 28, 14–22.

Corning, C. W. , & John, E. R. Effect of ribonuclease on retention of conditioned response in regenerated planarians. Science, 1961, 134, 1363–1365.

Craft, M. Tranquillizers in mental deficiency: hydroxyzine. J. ment. Sci., 1957, 103, 855–857.

Craft, M. Tranquillizers in mental deficiency: meprobamate. J. ment. Def. Res., 1958, 2, 17.

Craft, M. Mental disorder in the defective: the use of tranquillizers. Amer. J. ment. Def., 1959, 64, 63–71.

Cutler, M. , Little, J. W. , & Strauss, A. A. Effect of Benzedrine on mentally deficient children. Amer. J. ment. Def., 1940, 45, 59–65.

Cytryn, L. , Gilbert, A. , & Eisenberg, L. The effectiveness of tranquilizing drugs plus supportive psychotherapy in treating behavior disorders of children: a double-blind study of eighty outpatients. Amer. J. Orthopsychiat., 1960, 30, 113–128.

D'Amato, G. Chlordiazepoxide in management of school phobia. Dis. nerv. Syst., 1962, 23, 292–295.

Darken, M. A. Puromycin inhibition of protein synthesis. Pharmacol. Rev., 1964, 16, 223–243.

David, L. Push-button brain. This Week mag., Feb. 13, 1966, 4–5.

Davies, T. S. A monoamine oxidase inhibitor (Niamid) in the treatment of the mentally subnormal. J. ment. Sci., 1961, 107, 115–118.

Davis, J. M. Efficacy of tranquilizing and antidepressant drugs. Arch. gen. Psychiat., 1965, 13, 552–572.

Denhoff, E. Personal communication. Sept. 29, 1966.

DiMascio, A. , & Klerman, G. L. Experimental human psychopharmacology: the role of non-drug factors. In G. J. Sarwer-Foner (Ed.), The dynamics of psychiatric drug therapy. Springfield, Ill.: Thomas, 1960. Pp. 56–92.

Effron, A. S. , & Freedman, A. M. The treatment of behavior disorders in children with Benadryl. J. Pediat., 1953, 42, 261–266.

Eisenberg, L. Basic issues in drug research with children: opportunities and limitations of a pediatric age group. In S. Fisher (Ed.), Child research in psychopharmacology. Springfield, Ill.: Thomas, 1959. Pp. 21–35.

Eisenberg, L. Role of drugs in treating disturbed children. Children, 1964, 11, 167–173.

Eisenberg, L. , Gilbert, A. , Cytryn, L. , & Molling, P. A. The effectiveness of psychotherapy alone and in conjunction with perphenazine or placebo in the treatment of neurotic and hyperkinetic children. Amer. J. Psychiat., 1961, 117, 1088–1093.

Eisenberg, L. , Lachman, R. , Molling, P. A. , Lockner, A. , Mizelle, J. D. , & Conners, C. K. A psychopharmacologic experiment in a training school for delinquent boys: methods, problems, findings. Amer. J. Orthopsychiat., 1963, 33, 431–447.

Esen, F. M. , & Durling, D. Thorazine in the treatment of mentally retarded children. Arch. Pediat., 1956, 73, 168–173.

Esen, F. M. , & Durling, D. The treatment of 14 mentally retarded boys with Sparine. Arch. Pediat., 1957, 74, 471–474.

Eveloff, H. H. Psychopharmacologic agents in child psychiatry. Arch. gen. Psychiat., 1966, 14, 472–481.

Faretra, G. , & Gozun, C. The use of drug combinations in pediatric psychiatry. Curr. Ther. Res., 1964, 6, 340–343.

Ferster, C. B. , & DeMyer, M. K. Increased performance of an autistic child with prochlorperazine administration. J. exp. Anal. Behav., 1961, 4, 84.

Fine, R. H. Clinical experience with trifluoperazine in the severely retarded. J. Neuropsychiat., 1964, 5, 370–372.

Fischer, E. Reserpine ("Serpasil") in mental deficiency practice. J. ment. Sci., 1956, 102, 542–545.

Fish, B. Drug therapy in child psychiatry: psychological aspects. Compr. Psychiat., 1960, 1, 55–61. (a)

Fish, B. Drug therapy in child psychiatry: pharmacological aspects. Compr. Psychiat., 1960, 1, 212–227. (b)

Fish, B. The influence of maturation and abnormal development on the responses of disturbed children to drugs. In Third world congress of psychiatry-proceedings. Vol. II. Montreal: McGill Univ. Press, 1961. Pp. 1341–1344.

Fisher, S. (Ed.) Child research in psychopharmacology. Springfield, Ill.: Thomas, 1959.

Freed, H. Current status of the tranquilizers and of child analysis in child psychiatry. Dis. nerv. Syst., 1961, 22, 434–437.

Freed, H. The chemistry and therapy of behavior disorders in children. Springfield, Ill.: Thomas, 1962.

Freed, H. , Abrams, J. , & Peifer, C. Reading disability: a new therapeutic approach and its implications. J. clin. exp. Psychopath. & quart. Rev. Psychiat. Neurol., 1959, 20, 251–259.

Freed, H. , & Peifer, C. Treatment of hyperkinetic emotionally disturbed children with prolonged administration of chlorpromazine. Amer. J. Psychiat., 1956, 113, 22–26. (a)

Freed, H. , & Peifer, C. Some considerations on the use of chlorpromazine in a child psychiatry clinic. J. clin. exp. Psychopath. & quart. Rev. Psychiat. Neurol., 1956, 17, 164–169. (b)

Freedman, A. M. Drug therapy in behavior disorders. Pediat. Clin. N. Amer., 1958, 5, 573–584.

Freedman, A. M. Discussion [of Eisenberg's paper]. In S. Fisher (Ed.), Child research in psychopharmacology. Springfield, Ill.: Thomas, 1959. Pp. 42–47.

Freedman, A. M. , Effron, A. S. , & Bender, L. Pharmacotherapy in children with psychiatric illness. J. nerv. ment. Dis., 1955, 122, 479–486.

Freedman, A. M. , Kremer, M. W. , Robertiello, R. C. , & Effron, A. S. The treatment of behavior disorders in children with Tolserol. J. Pediat., 1955, 47, 369–372.

Froelich, R. E. , & Heckel, R. V. The psychological effects of methylphenidate. J. clin. exp. Psychopath. & quart. Rev. Psychiat. Neurol., 1962, 23, 91–98.

Fuller, J. L. Effects of drugs on psychological development. Ann. N. Y. Acad. Sci., 1962, 96, 199–204.

Fuller, J. L. , Clark, L. D. , & Waller, M. B. Effects of chlorpromazine upon psychological development in the puppy. Psychopharmacologia, 1960, 1, 393–407.

Gadson, E. J. Glutamic acid and mental deficiency. Amer. J. ment. Def., 1951, 55, 521–528.

Garfield, S. L. , Helper, M. M. , Wilcott, R. C. , & Muffly, R. Effects of chlorpromazine on behavior in emotionally disturbed children. J. nerv. ment. Dis., 1962, 135, 147–154.

Gatski, R. L. Chlorpromazine in the treatment of emotionally maladjusted children. J.A.M.A., 1955, 157, 1298–1300.

Geller, S. J. Comparison of a tranquilizer and a psvchic energizer used in treatment of children with behavioral disorders. J.A.M.A., 1960, 174, 481–484.

Gillie, A. K. The use of Pacatal in low-grade mental defectives. J. ment. Sci., 1957, 103, 402–405.

Grant, Q. Psychopharmacology in childhood emotional and mental disorders. J. Pediat., 1962, 61, 626–637.

Grossman, H. J. Psychopharmacology in learning and behavioral disorders of children. In W. Cruickshank (Ed.), The teacher of brain-injured children. Syracuse: Syracuse Univ. Press, 1966. Pp. 245–254.

Haefner, D. P. , Sacks, J. M. , & Mason, A. S. Physicians' attitudes toward chemotherapy as a factor in psychiatric patients' responses to medication. J. nerv. ment. Dis., 1960, 131, 64–69.

Harman, C. , & Winn, D. Clinical experience with chlorprothix$$ene in disturbed children--a comparative study. Int. J. Neuropsychiat., 1966, 2, 72–77.

Hartlage, L. C. Effects of chlorpromazine on learning. Psychol. Bull., 1965, 64, 235–245.

Hartry, A. L. , Keith-Lee, P. , & Morton, W. D. Planaria: memory transfer through cannibalism reexamined. Science, 1964, 146, 274–275.

Hea$$fon-Ward, W. A. Inference and suggestion in a clinical trial (Niamid in mongolism). J. ment. Sci., 1962, 108, 865–870.

Hea$$fon-Ward, W. A. , & Jancar, J. A controlled clinical trial of me$$probamate in the management of difficult and destructive female mental defectives. J. ment. Sci., 1958, 104, 454–456.

Helper, M. M. , Wilcott, R. C. , & Garfield, S. L. Effects of chlorpromazine on learning and related processes in emotionally disturbed children. J. consult. Psychol., 1963, 27, 1–9.

Hilgard, E. R. , & Marquis, D. G. The definition of learning. In Hilgard, E. R. , & Marquis, D. G. (eds). Conditioning and learning. New York: Appleton, 1961. Pp. 1–13.

Himwich, H. E. , Costa, E. , Rinaldi, F. , & Rudy, L. H. Triflupromazine and trifluoperazine in the treatment of disturbed mentally defective patients. Amer. J. ment. Def., 1960, 64, 711–712.

Hollister, L. E. Psychopharmacologic drugs. J.A.M.A., 1966, 196, 411–413.

Horenstein, S. Reserpine and chlorpromazine in hyperactive mental defectives. Amer. J. ment. Def., 1957, 61, 525–529.

Houze, M. , Wilson, H. D. , & Goodfellow, H. D. L. Treatment of mental deficiency with alpha tocopherol. Amer. J. ment. Def., 1964, 69, 328–329.

Hunt, B. R. , Frank, T. , & Krush, T. P. Chlorpromazine in the treatment of severe emotional disorders of children. A.M.A. J. Dis. Child., 1956, 91, 268–277.

Hunter, H. , & Stephenson, G. M. Chlorpromazine and trifluoperazine in the treatment of behavioral abnormalities in the severely subnormal child. Brit. J. Psychiat., 1963, 109, 411–417.

Ison, M. G. The effect of Thorazine on Wechsler scores. Amer. J. ment. Def., 1957, 62, 543–547.

Johnston, A. H. , & Martin, C. H. The clinical use of reserpine and chlorpromazine in the care of the mentally deficient. Amer. J. ment. Def., 1957, 62, 292–294.

Jones, D. Psychopharmacological therapy with the mentally retarded. Ment. ret. Abstrs., 1966, 3 (1), 21–27.

Katz, B. E. Education of cerebral palsied children -- the role of meprobamate: a preliminary evaluation. J. Pediat., 1958, 53, 467–475.

Kirk, D. L. , & Bauer, A. M. Effects of reserpine (Serpasil) on emotionally maladjusted high grade mental retardates. Amer. J. ment. Def., 1956, 60, 779–784.

Knobel, M. The environmental "antidrug" effect. Psychiatry, 1960, 23, 403–407.

Knobel, M. Newer dynamic considerations on psychopharmacology for the hyperkinetic child. In Third world congress of psychiatry--proceedings, Vol. II. Montreal: McGill Univ. Press, 1961. Pp. 1344–1348.

Knobel, M. Psychopharmacology for the hyperkinetic child. Arch. gen. Psychiat., 1962, 6, 198–202.

Knobel, M. , & Lytton, G. J. Diagnosis and treatment of behavior disorders in children. Dis. nerv. Syst., 1959, 20, 334–340.

Knobel, M. , Wolman, M. B. , & Mason, E. Hyperkinesis and organicity in children. A.M.A. Arch. gen. Psychiat., 1959, 1, 310–321.

Kraft, I. A. , Marcus, I. M. , Wilson, W. , Swander, D. , Rummage, N. , & Schulhofer, E. Methodological problems in studying the effect of tranquilizers in children with special reference to meprobamate. Sth. med. J., 1959, 52, 179–185.

Kugel, R. B. , & Alexander, T. The effect of a central nervous system stimulant (deanol) on behavior. Pediatrics, 1963, 31, 651–655.

Kugelmass, I. N. Psychochemotherapy of mental deficiency in children. Int. Rec. Med., 1956, 169, 323–338.

Kugelmass, I. N. Chemical therapy of mentally retarded children. Int. Rec. Med., 1959, 172, 119–136.

Kurland, A. A. Placebo effect. In L. Uhr & J. G. Miller (Eds.), Drugs and behavior. New York: Wiley, 1960. Pp. 156–165.

Lane, G. G. , Huber, W. G. , & Smith, F. L. The effect of chlorpromazine on the behavior of disturbed children. Amer. J. Psychiat., 1958, 114, 937–938.

Laufer, M. W. , & Denhoff, E. Hyperkinetic behavior syndrome in children. J. Pediat., 1957, 50, 463–474.

Laufer, M. W. , Denhoff, E. , & Solomons, G. Hyperkinetic impulse disorder in children's behavior problems. Psychosom. Med., 1957, 19, 38–49.

LaVeck, G. D. , & Buckley, P. The use of psychopharmacologic agents in retarded children with behavior disorders. J. chron. Dis., 1961, 13, 174–183.

LaVeck, G. D. , de la Cruz, F. , & Simundson, E. Fluphenazine in the treatment of mentally retarded children with behavior disorders. Dis. nerv. Syst., 1960, 21, 82–85.

Lehman, E. , Haber, J. , & Lesser, S. R. The use of reserpine in autistic children. J. nerv. ment. Dis., 1957, 125, 351–356.

Levy, J. M. , Jones, B. E. , & Croley, H. T. Effects of methylphenidate (Ritalin) on drug-induced drowsiness in mentally retarded patients. Amer. J. ment. Def., 1957, 62, 284–287.

Lewis, I. Trial of diazepam in myotonia. Neurology (Minneap.), 1966, 16, 831–836.

Liberman, R. A criticism of drug therapy in psychiatry. A.M.A. Arch. gen. Psychiat., 1961, 4, 131–136.

Liberman, R. An analysis of the placebo phenomenon. J. chron. Dis., 1962, 15, 761, 783.

Litchfield, H. R. Clinical evaluation of meprobamate in disturbed and pre-psychotic children. Ann. N. Y. Acad. Sci., 1957, 67, 828–831.

Lombard, J. P. , Gilbert, J. G. , & Donofrio, A. F. The effects of glutamic acid upon the intelligence, social maturity and adjustment of a group of mentally retarded children. Amer. J. ment. Def., 1955, 60, 122–132.

Lourie, R. S. Psychoactive drugs in pediatrics. Pediatrics, 1964, 34, 691–693.

Louttit, R. T. Chemical facilitation of intelligence among the mentally retarded. Amer. J. ment. Def., 1965, 69, 495–501.

Low, N. L. , & Myers, G. G. Suvren in brain-injured children. J. Pediat., 1958, 52, 259–263.

Lucas, A. R. Psychopharmacologic treatment. In C. R. Shaw . The psychiatric disorders of childhood. New York: Appleton, 1966. Pp. 387–402.

MacColl, K. Chlorpromazine hydrochloride (Largactil) in the treatment of the disturbed mental defective. Amer. J. ment. Def., 1956, 61, 378–389.

McConnell, J. V. Memory transfer through cannibalism in planarians. J. Neuropsychiat., 1962, 3 (Suppl. 1), 42–48.

McConnell, T. R., Jr. , Cromwell, R. L. , Bialer, I. , & Son, C. D. Studies in activity level: VII. effects of amphetamine drug administration on the activity level of retarded children. Amer. J. ment. Def., 1964, 68, 647–651.

McDermott, J. F. A specific placebo effect encountered in the use of Dexedrine in a hyperactive child. Amer. J. Psychiat., 1965, 121, 923–924.

McGaugh, J. L. , & Petrinovich, L. Comments concerning the basis of learning enhancement with central nervous system stimulants. Psychol. Rep., 1963, 12, 211–214.

McGaugh, J. L. , & Petrinovich, L. Effects of drugs on learning and memory. Int. Rev. Neurobiol., 1965, 8, 139–196.

McLaughlin, B. E. , Duffy, R. E. , & Ryan, F. R. Chemotherapy as adjunctive treatment for emotionally disturbed children. Dis. nerv. Syst., 1962, 23, 95–98.

Mebane, J. C. Use of deanol with disturbed juvenile offenders. Dis. nerv. Syst., 1960, 21, 642–643.

Meier, C. W. , & Huff, F. W. Altered adult behavior following chronic drug administration during infancy and prepuberty. J. comp. physiol. Psychol., 1962, 55, 469–471.

Miksztal, M. W. Chlorpromazine (Thorazine) and reserpine in residential treatment of neuropsychiatric disorders in children. J. nerv. ment. Dis., 1956, 123, 477–479.

Milliken, J. R. , & Standen, J. L. An investigation into the effects of glutamic acid on human intelligence. J. Neurol. Neurosurg. Psychiat., 1951, 14, 47–54.

Mitchell, A. C. , Hargis, C. H. , McCarry, F. , & Power, C. Effects of prochlorperazine (Compazine) therapy on educability in disturbed mentally retarded adolescents. Amer. J. ment. Def., 1959, 64, 57–62.

Molitch, M. , & Sullivan, J. P. The effect of Benzedrine sulfate on children taking the New Stanford Achievement Test. Amer. J. Orthopsychiat., 1937, 7, 519–522.

Molling, P. A. , Lockner, A. W. , Sauls, R. J. , & Eisenberg, L. Committed delinquent boys. A.M.A Arch. gen. Psychiat., 1962, 7, 70–76.

Mooney, W. E. The placebo: a bibliography (1955-1960). Psychiat. Communications, 1961, 4, 21–26.

Morris, J. V. , MacGillivray, R. C. , & Mathieson, C. M. The results of the experimental administration of amphetamine sulphate in oligophrenia. J. ment. Sci., 1955, 101, 131–140.

Moskowitz, H. Benzedrine therapy for the mentally handicapped. Amer. J. ment. Def., 1941, 45, 540–543.

Nash, H. The design and conduct of experiments on the psychological effects of drugs. In L. Uhr & J. G. Miller (Eds). Drugs and behavior, New York: Wiley, 1960. Pp. 128–155.

Nash, H. The double-blind procedure. J. nerv. ment. Dis., 1962, 134, 34–47.

N. Y. Times. Animal learning transferred by RNA injections. Dec. 1, 1965.

Noce, R. H. , Williams, D. B. , & Rapaport, W. Reserpine (Serpasil) in the management of the mentally ill and mentally retarded. J.A.M.A., 1954, 156, 821–824.

Oettinger, L. Meratran: preliminary report on a new drug for the treatment of behavior disorders in children. Dis. nerv. Syst., 1955, 16, 299–302.

Oettinger, L. The use of deanol in the treatment of disorders of behavior in children. J. Pediat., 1958, 53, 671–675.

Oettinger, L. Chlorprothixene in the management of problem children. Dis. nerv. Syst., 1962, 23, 568–571.

Ostow, M. Method and madness: a critique of current methodology in psychiatric drug research. J. new Drugs, 1965, 5, 3–8.

Pallister, P. D. , & Stevens, R. R. Effects of Serpasil in small dosage on behavior, intelligence and physiology. Amer. J. ment. Def., 1957, 62, 267–274.

Paredes, A. , Gogerty, J. H. , & West, L. J. Psychopharmacology. In J. H. Masserman (Ed.), Current psychiatric therapies, Vol. I. New York: Grune & Stratton, 1961, Pp. 54–85.

Pasamanick, B. Anticonvulsant drug therapy of behavior problem children with abnormal electroencephalograms. A.M.A. Arch. Neurol. Psychiat., 1951, 65, 752–756.

Phila. Inquirer. Scientists warned on mind tampering. Jan. 2, 1966, Science Section, p. 8.

Pilkington, T. L. Prochlorperazine (Stemetil) in mental deficiency. J. ment. Sci., 1959, 105, 215–219.

Pilkington, T. L. Comparative effects of Librium and Taractan on behavior disorders of mentally retarded children. Dis. nerv. Syst., Oct., 1961, 22, 573–575.

Pilkington, T. L. A report on "Tofranil" in mental deficiency. Amer. J. ment. Def., 1962, 66, 729–732.

Piuck, C. L. Clinical impressions of hydroxyzine and other tranquilizers in a child guidance clinic. Dis. nerv. Syst., 1963, 24, 483–488.

Pribram, K. H. The new neurology: memory, novelty, thought, and choice. In G. Glaser (Ed.), EEG & Behavior. New York: Basic Books, 1963. Pp. 149–173.

Reiss, M. , Wakoh, T. , Hillman, J. C. , Pearse, J. J. , Reiss, J. M. , & Daley, N. Action of anabolic steroids on the metabolism of mentally retarded boys. Amer. J. ment. Def., 1966, 70, 520–528.

Resnick, O. The role of diet in psychopharmacology. Psychiat. Opin., 1965, Fall, 14–17.

Rettig, J. H. Chlorpromazine for the control of psychomotor excitement in the mentally deficient: a preliminary study. J. nerv. ment. Dis., 1955, 122, 190–194.

Rickels, K. Psychopharmacologic agents: a clinical psychiatrist's individualistic point of view: patient and doctor variables. J. nerv. ment. Dis., 1963, 136, 540–549.

Rosati, D. Systematic treatment of psychosis: a summing up of experience with ataractic medication. Amer. J. Psychiat., 1965, 121, 902–906.

Rosenblum, S. Practices and problems in the use of tranquilizers with exceptional children. In E. Trapp & P. Himelstein (Eds.), Readings on the exceptional child. New York: Appleton, 1962. Pp. 639–657.

Rosenblum, S. , Buoniconto, P. , & Graham, B. D. "Compazine" vs. placebo: a controlled study with educable, emotionally disturbed children. Amer. J. ment. Def., 1960, 64, 713–717.

Rosenblum, S. , Callahan, R. J. , Buoniconto, P. , Graham, B. D. , & Deatrick, R. W. The effects of tranquilizing medication (reserpine) on behavior and test performance of maladjusted, high-grade retarded children. Amer. J. ment. Def., 1958, 62, 663–671.

Rudy, L. H. , Himwich, H. E. , & Rinaldi, F. A clinical evaluation of psychopharmacological agents in the management of disturbed mentally defective patients. Amer. J. ment. Def., 1958, 62, 855–860.

Schulman, J. L. , & Clarinda, S. R. The effect of promazine on the activity level of retarded children. Pediatrics, 1964, 33, 271–275.

Segal, L. J. , & Tansley, A. E. A clinical trial with hydroxyzine (Atarax) on a group of maladjusted educationally subnormal children. J. ment. Sci., 1957, 103, 677–681.

Shaw, C. R. , Lockett, H. J. , Lucas, A. R. , Lamontagne, C. H. , & Grimm, F. Tranquilizer drugs in the treatment of emotionally disturbed children. Inpatients in a residential treatment center. J. Amer. Acad. Child Psychiat., 1963, 2, 725–742.

Smith, S. W. Trifluoperazine in children and adolescents with marked behavior problems. Amer. J. Psychiat., 1965, 122, 702–703.

Soblen, R. A. , & Saunders, J. C. Monoamine oxidase inhibitor therapy in adolescent psychiatry. Dis. nerv. Syst., 1961, 22, 96–100.

Solomons, G. The hyperactive child. J. Iowa med. Soc., 1965, 55, 464–469.

Spencer, S. M. The pill that helps you remember. Sat. Eve. Post, Sept. 24, 1966, 64–68.

Sprogis, G. R. , Lezdins, V. , White, S. D. , Ming, C. , Lanning, M. , Drake, M. E. , & Wyckoff, G. Comparative study on Thorazine and Serpasil in the mental defective. Amer. J. ment. Def., 1957, 61, 737–742.

Tarjan, G. Lowery, V. E. , & Wright, S. W. Use of chlorpromazine in 278 mentally deficient patients. A.M.A. J. Dis. Child., 1957, 94, 294–300.

Timberlake, W. H. , Belmont, E. H. , & Ogonik, J. The effect of reserpine in 200 mentally retarded children. Amer. J. ment. Def., 1957, 62, 61–66.

Time. A molecule for memory? Jan. 7, 1966, p. 66.

Uhlenhuth, E. J. , Canter, A. , Neustadt, J. O. , & Payson, H. E. The symptomatic relief of anxiety with meprobamate, phenobarbital and placebo. Amer. J. Psychiat., 1959, 115, 905–910.

Uhr, L. , & Miller, J. G. , (Eds.) Drugs and behavior. New York: Wiley, 1960.

Vogel, W. , Broverman, D. M. , Draguns, J. G. , & Klaiber, E. L. The role of glutamic acid in cognitive behaviors. Psychol. Bull., 1965, 65, 367–382.

Waites, L. , & Keele, D. K. Fluphenazine in management of disturbed mentally retarded children. Dis. nerv. Syst., 1963, 24, 113–114.

Wardell, D. W. , Rubin, H. K. , & Ross, R. T. Use of reserpine and chlorpromazine in disturbed mentally defective patients. Amer. J. ment. Def., 1958, 63, 330–344.

Weiss, B. , & Laties, V. G. Enhancement of human performance by caffeine and the amphetamines. Pharmacol. Rev., 1962, 14, 1–36.

Werry, J. S. , Weiss, G. , Douglas, V. , & Martin, J. Studies on the hyperactive child. 3: The effect of chlorpromazine upon behavior and learning ability. J. Amer. Acad. Child Psychiat., 1966, 5, 292–312.

Wolf, S. , Doering, C. R. , Clark, M. L. , & Hagans, J. A. Chance distribution and the placebo "reactor". J. lab. clin. Med., 1957, 49, 837–841.

Wolf, S. , & Pinsky, R. H. Effects of placebo administration and occurrence of toxic reactions. J.A.M.A., 1954, 155, 339–341.

Wolfson, I. N. Clinical experience with Serpasil and Thorazine in treatment of disturbed behavior of mentally retarded. Amer. J. ment. Def., 1957, 62, 276–283.

Wright, W. B. Azacyclonol in mental deficiency practice: a preliminary report. J. ment. Sci., 1958, 104, 485.

Zimmerman, F. T. , & Burgemeister, B. B. Effects of reserpine on the behavior problems of children. N. Y. J. Med., 1957, 57, 3132–3140.

Zimmerman, F. T. , & Burgemeister, B. B. Action of methylphenidylacetate (Ritalin) and reserpine in behavior disorders in children and adults. Amer. J. Psychiat., 1958, 115, 323–328.

Zimmerman, F. T. , & Burgemeister, B. B. A controlled experiment of glutamic acid therapy. A.M.A. Arch. Neurol. Psychiat., 1959, 81, 639–648.

Zrull, J. P. , Westman, J. C. , Arthur, B. , & Rice, D. L. A comparison of diazepam, d-amphetamine and placebo in the treatment of the hyperkinetic syndrome in children. Amer. J. Psychiat., 1964, 121, 388–389.

Zrull, J. P. , Westman, J. C. , Arthur, B. , & Rice, D. L. An evaluation of methodology used in the study of psychoactive drugs for children. J. Amer. Acad. Child Psychiat., 1966, 5, 284–291.